Home/Filings/4/0001127602-23-014093
4//SEC Filing

Pelletier Johonna Marie 4

Accession 0001127602-23-014093

CIK 0000816956other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:25 PM ET

Size

31.7 KB

Accession

0001127602-23-014093

Insider Transaction Report

Form 4
Period: 2023-04-28
Pelletier Johonna Marie
Treasurer and VP, Tax
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-28$41.93/sh+2,000$83,8604,634 total
  • Exercise/Conversion

    Common Stock

    2023-04-28$59.96/sh+5,400$323,78410,034 total
  • Exercise/Conversion

    Common Stock

    2023-04-28$78.76/sh+5,400$425,30415,434 total
  • Exercise/Conversion

    Common Stock

    2023-04-28$97.69/sh+5,100$498,21920,534 total
  • Exercise/Conversion

    Common Stock

    2023-04-28$122.55/sh+4,800$588,24025,334 total
  • Sale

    Common Stock

    2023-04-28$127.06/sh1,317$167,33824,017 total
  • Sale

    Common Stock

    2023-04-28$126.45/sh2,000$252,90022,017 total
  • Sale

    Common Stock

    2023-04-28$126.18/sh5,400$681,37211,217 total
  • Sale

    Common Stock

    2023-04-28$126.37/sh5,100$644,4876,117 total
  • Sale

    Common Stock

    2023-04-28$126.33/sh4,800$606,3841,317 total
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-04-285,4000 total
    Exercise: $59.96Exp: 2028-03-01Common Stock (5,400 underlying)
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-04-285,4002,700 total
    Exercise: $78.76Exp: 2029-03-01Common Stock (5,400 underlying)
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-04-285,1005,100 total
    Exercise: $97.69Exp: 2030-03-02Common Stock (5,100 underlying)
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-04-284,8007,200 total
    Exercise: $122.55Exp: 2031-03-01Common Stock (4,800 underlying)
  • Sale

    Common Stock

    2023-04-28$126.43/sh5,400$682,72216,617 total
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-04-282,0000 total
    Exercise: $41.93Exp: 2027-03-01Common Stock (2,000 underlying)
Footnotes (8)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.01 to $127.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.44 to $126.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.08 to $126.47. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.27 to $126.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F7]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  • [F8]The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Issuer

CONMED Corp

CIK 0000816956

Entity typeother

Related Parties

1
  • filerCIK 0001741585

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:25 PM ET
Size
31.7 KB